SC
SGNT

Steven Cohen’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Steven Cohen’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-118,100
Closed -$1.44M – 964
2016
Q1 		$1.44M Sell
118,100
-73,500
-38% -$1.03M 0.01% 588
2015
Q4 		$3.05M Sell
191,600
-37,900
-17% -$597K 0.03% 493
2015
Q3 		$3.52M Sell
229,500
-15,400
-6% -$333K 0.03% 474
2015
Q2 		$5.95M Buy
+244,900
New +$5.87M 0.04% 418

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Steven Cohen's SGNT Position: Q2 2016 in Review

Steven Cohen sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 118,100 shares — an estimated $1.44M sold.

Steven Cohen first reported a position in SGNT in Q2 2015 and held it in 4 quarters. The position peaked at $5.95M in Q2 2015. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • Steven Cohen reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Steven Cohen sold 118,100 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $1.44M.
  • Steven Cohen first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2015 and held it in 4 quarters.
  • Steven Cohen's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $5.95M in Q2 2015.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on Point72 Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.